Today before the opening
bell, Galena Biopharma announced that Mark J. Ahn, Ph.D., President and Chief
Executive Officer, will be presenting a corporate update at the 2014 Leerink
Global Healthcare Conference. The presentation will take place on Wednesday,
February 12, 2014 at 3:55 p.m. ET at the Waldorf Astoria Hotel in New York, New
York.
The presentation will be
webcast and available on the investors section of the company’s website at
www.galenabiopharma.com.
Galena Biopharma is focused
on developing and commercializing targeted oncology treatments to address major
unmet medical needs and advance cancer care. The company’s peptide vaccine
immunotherapies harness the patient’s own immune system to identify and destroy
cancer cells. Utilizing peptide immunogens has many clinical advantages,
including an excellent safety profile and long-lasting protection through
immune system activation and convenient delivery.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
